Table 1.

Dose response of IL-18 on hematologic effect

TreatmentSerum IL-18 (ng/mL)WBC (counts/μL)Lymphocyte (%)Neutrophil (%)Eosinophil (%)
Phosphate buffered saline Not detected 2856 ± 179.04 85.10 ± 2.21 10.90 ± 1.66 0.70 ± 0.25 
  (n = 5) (n = 5) (n = 5) (n = 5) 
IL-18 (2.0 μg/mouse/day) 201.61 ± 14.84* 2260 ± 156.46 66.90 ± 2.59 26.70 ± 2.381-153 3.60 ± 0.681-153 
 (n = 3) (n = 5) (n = 5) (n = 5) (n = 5) 
IL-18 (0.6 μg/mouse/day) 79.72 ± 3.95* 2229 ± 86.70NS 78.67 ± 1.74NS 16.50 ± 3.00NS 1.33 ± 0.17NS 
 (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) 
IL-18 (0.2 μg/mouse/day) 22.47 ± 3.10 2240 ± 105.03NS 83.00 ± 1.73NS 12.92 ± 2.08NS 1.00 ± 0.29NS 
 (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) 
TreatmentSerum IL-18 (ng/mL)WBC (counts/μL)Lymphocyte (%)Neutrophil (%)Eosinophil (%)
Phosphate buffered saline Not detected 2856 ± 179.04 85.10 ± 2.21 10.90 ± 1.66 0.70 ± 0.25 
  (n = 5) (n = 5) (n = 5) (n = 5) 
IL-18 (2.0 μg/mouse/day) 201.61 ± 14.84* 2260 ± 156.46 66.90 ± 2.59 26.70 ± 2.381-153 3.60 ± 0.681-153 
 (n = 3) (n = 5) (n = 5) (n = 5) (n = 5) 
IL-18 (0.6 μg/mouse/day) 79.72 ± 3.95* 2229 ± 86.70NS 78.67 ± 1.74NS 16.50 ± 3.00NS 1.33 ± 0.17NS 
 (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) 
IL-18 (0.2 μg/mouse/day) 22.47 ± 3.10 2240 ± 105.03NS 83.00 ± 1.73NS 12.92 ± 2.08NS 1.00 ± 0.29NS 
 (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) 

The numbers of white blood cells (WBC), lymphocytes, neutrophils, and eosinophils are shown as a mean ± SE of 5 or 3 mice immediately after 5 weeks of treatment with respective doses of IL-18. Serum IL-18 concentrations are shown as a mean ± SE of 3 mice immediately after 5 weeks of IL-18 treatment.

NS indicates not significant.

*

P < .01, compared with IL-18 (0.2 μg/mouse/day) (Dunnett test for multiple comparison).

P < .05.

P < .001, compared with PBS.

F1-153

P < .01, compared with PBS.

or Create an Account

Close Modal
Close Modal